期刊文献+

弥漫大B细胞淋巴瘤老年患者的药学监护

Pharmaceutical Care for Elderly Patients with Diffuse Large B Cell Lymphoma
下载PDF
导出
摘要 目的:通过临床药师参与17例弥漫大B细胞淋巴瘤老年患者的治疗实践,探讨药师在合理用药中发挥的作用。方法:临床药师积极参与了该病患者治疗方案的制定,针对患者药物选择、剂量调整、不良反应处理等提出合理化的建议,并对患者实施药学监护。结果:临床药师参与治疗,提高了临床治疗效果。结论:临床药师参与临床实践与临床医师密切配合,有助于更好地开展临床药学服务工作,促进临床合理用药,更好地为患者服务。 Objective: To investigate the role of clinical pharmacists in rational drug use through the pharmaceutical care for 17 patients with diffuse large B cell lymphoma. Methods: The clinical pharmacists actively participated in 17 patients' treatment, proposed reasonable suggestions on drug selection, dosage adjustment and side effect prevention, meanwhile took full implementation of pharmaceutical care. Results:The clinical pharmacists' participating in the treatment practice helped improve the clinical treatment effect. Conclusion: The clinical pharmacists cooperated with clinicians in clinical practices, so the clinical pharmacy service for patients can be improved.
出处 《药学与临床研究》 2015年第3期317-320,共4页 Pharmaceutical and Clinical Research
基金 福建省卫生厅青年课题(No.2013-1-8)
关键词 临床药师 弥漫大B细胞淋巴瘤 老年患者 Clinical pharmacist BCEL-1 Elderly patients
  • 相关文献

参考文献9

  • 1Mounier N, Heutte N, Thieblemont C, et al. Ten-yearrelative survival and causes of death in elderly patientstreated with RCHOP or CHOP in the GELA LNH-985 trial [J]. Clin Lymphoma Myeloma Leuk, 2012, 12(3): 151-4.
  • 2Musolino A, Boggiani D, Panebianco M, et al. Activityand safety of dose -adjusted infusional cyclophosphamide,doxorubicin, vincristine, and prednisonechemotherapy with rituximab in very elderly patientswith poor -prognostic untreated diffuse large B -cellnon-Hodgkin lymphoma[J]. Cancer, 2011, 117(5): 964-73.
  • 3Meguro A, Ozaki K, Sato K, et al. Rituximab plus70% cyclophosphamide, doxorubicin, vincristine andprednisone for Japanese patients with diffuse large B -cell lymphoma aged 70 years and older [J]. Leuk Lymphoma,2012, 53(1): 43-9.
  • 4Mori M, Murai Y, Suzuki K, et al. Study of optimalCHOP dose ranges for elderly patients with non -Hodgkin^s lymphoma [J]. Rinsho Ketsueki, 1999, 40(3):199-204.
  • 5Peyrade F, Jardin F, Thieblemont C, et al. Attenuatedimmunochemotherapy regimen (R-miniGHOP) in elderlypatients older than 80 years with diff use large B-celllymphoma: a multicentre, single-arm, phase 2 trial [J].Lancet Oncol, 2011, 12(5): 460-8.
  • 6NCCN. NCCN clinical Practice Guidelines in Oncology,Non-Hodgkin5 s lymphomas[EB/OL]. http://www.Nccn.org/professionals/physician_gls/pd£WHL.pdf.
  • 7van Dalen EC, Caron HN, Dickinson HO, et al. Cardioprotectiveinterventions for cancer patients receivinganthracyclines[J]. Cochrane Database Syst Rev, 2011,(6):GD003917.
  • 8Hiddemann W, Kneba M, Dreyling M. Frontline therapywith rituximab added to the combination of cyclophosphamide,doxorubicin, vincristine, and prednisone(CHOP) significantly improves the outcome for patientswith advanced-stage follicular lymphoma compared withtherapy with CHOP alone: results of a prospective randomizedstudy of the German Low -Grade LymphomaStudy Group[J]. Blood, 2005, 106(12): 3725-32.
  • 9NCCN. NCCN Clinical Practice Guidelines In Oncology,Prevention and Treatment of Cancer-Relatedlnfections[EB/OL]. http://www.Nccn.org/professionals/physician_gls/pdf/infections.pdf.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部